Two Sigma Advisers’s CONMED CNMD Stock Holding History

Two Sigma Advisers’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-114,200	Closed	-$4.64M	–	461
2025 Q4	$4.64M	Buy	114,200 +60,600	+113%	+$2.64M	0.01%	847
2025 Q3	$2.52M	Buy	53,600 +3,300	+7%	+$171K	0.01%	1028
2025 Q2	$2.62M	Sell	50,300 -15,800	-24%	-$867K	0.01%	997
2025 Q1	$3.99M	Buy	+66,100	New	+$4.26M	0.01%	866
2024 Q3	–	Sell	-23,900	Closed	-$1.66M	–	2322
2024 Q2	$1.66M	Sell	23,900 -27,900	-54%	-$2.04M	﹤0.01%	1295
2024 Q1	$4.15M	Sell	51,800 -40,400	-44%	-$3.6M	0.01%	851
2023 Q4	$10.1M	Sell	92,200 -22,200	-19%	-$2.3M	0.02%	524
2023 Q3	$11.5M	Buy	+114,400	New	+$13.1M	0.03%	433
2023 Q1	–	Sell	-18,900	Closed	-$1.68M	–	2607
2022 Q4	$1.68M	Buy	18,900 +7,800	+70%	+$647K	﹤0.01%	1326
2022 Q3	$890K	Sell	11,100 -2,600	-19%	-$245K	﹤0.01%	1573
2022 Q2	$1.31M	Buy	13,700 +7,200	+111%	+$864K	﹤0.01%	1450
2022 Q1	$966K	Sell	6,500 -700	-10%	-$97.7K	﹤0.01%	1652
2021 Q4	$1.02M	Buy	7,200 +2,600	+57%	+$368K	﹤0.01%	1552
2021 Q3	$602K	Sell	4,600 -7,800	-63%	-$1.02M	﹤0.01%	1846
2021 Q2	$1.7M	Buy	12,400 +3,300	+36%	+$452K	﹤0.01%	1371
2021 Q1	$1.19M	Sell	9,100 -14,300	-61%	-$1.72M	﹤0.01%	1559
2020 Q4	$2.62M	Sell	23,400 -5,800	-20%	-$549K	0.01%	1121
2020 Q3	$2.3M	Sell	29,200 -13,000	-31%	-$1.06M	0.01%	1088
2020 Q2	$3.04M	Buy	42,200 +20,500	+94%	+$1.43M	0.01%	1004
2020 Q1	$1.24M	Buy	+21,700	New	+$2M	﹤0.01%	1365
2019 Q1	–	Sell	-19,022	Closed	-$1.22M	–	2317
2018 Q4	$1.22M	Sell	19,022 -2,900	-13%	-$198K	﹤0.01%	1389
2018 Q3	$1.74M	Sell	21,922 -2,500	-10%	-$193K	﹤0.01%	1302
2018 Q2	$1.79M	Sell	24,422 -14,100	-37%	-$959K	﹤0.01%	1350
2018 Q1	$2.44M	Buy	38,522 +33,300	+638%	+$1.99M	0.01%	1158
2017 Q4	$266K	Hold	5,222	–	–	﹤0.01%	1994
2017 Q3	$274K	Buy	5,222 +500	+11%	+$25.1K	﹤0.01%	1957
2017 Q2	$241K	Sell	4,722 -4,500	-49%	-$223K	﹤0.01%	2060
2017 Q1	$410K	Buy	9,222 +1,000	+12%	+$43K	﹤0.01%	1971
2016 Q4	$363K	Sell	8,222 -6,700	-45%	-$285K	﹤0.01%	2008
2016 Q3	$598K	Sell	14,922 -18,300	-55%	-$777K	﹤0.01%	1595
2016 Q2	$1.59M	Sell	33,222 -43,300	-57%	-$1.83M	0.01%	957
2016 Q1	$3.21M	Sell	76,522 -1,800	-2%	-$70.6K	0.02%	642
2015 Q4	$3.45M	Buy	78,322 +14,400	+23%	+$625K	0.02%	564
2015 Q3	$3.05M	Sell	63,922 -15,100	-19%	-$829K	0.02%	611
2015 Q2	$4.61M	Sell	79,022 -1,100	-1%	-$59.3K	0.03%	505
2015 Q1	$4.04M	Buy	80,122 +8,700	+12%	+$426K	0.03%	547
2014 Q4	$3.21M	Sell	71,422 -50,500	-41%	-$2.12M	0.02%	639
2014 Q3	$4.49M	Buy	121,922 +22,500	+23%	+$893K	0.03%	539
2014 Q2	$4.39M	Buy	99,422 +19,600	+25%	+$889K	0.03%	519
2014 Q1	$3.47M	Buy	79,822 +41,900	+110%	+$1.87M	0.03%	546
2013 Q4	$1.61M	Sell	37,922 -3,800	-9%	-$144K	0.02%	867
2013 Q3	$1.42M	Buy	41,722 +3,883	+10%	+$127K	0.02%	782
2013 Q2	$1.18M	Buy	+37,839	New	+$1.23M	0.02%	773

Other funds holding CNMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

Two Sigma Advisers's CNMD Position: Q1 2026 in Review

Two Sigma Advisers sold out of CONMED (CNMD) in Q1 2026, closing a stake of 114,200 shares — an estimated $4.64M sold.

Two Sigma Advisers first reported a position in CNMD in Q2 2013 and held it in 43 quarters. The position peaked at $11.5M in Q3 2023. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

Two Sigma Advisers reported no remaining CONMED position as of Q1 2026 after selling out during the quarter.
Two Sigma Advisers sold 114,200 CONMED shares in Q1 2026, an estimated $4.64M.
Two Sigma Advisers first reported a position in CONMED in Q2 2013 and held it in 43 quarters.
Two Sigma Advisers's CONMED position peaked at $11.5M in Q3 2023.
236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.